Development of anisamide-targeted PEGylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice

Limei Wang,1,2 Jin Pei,1 Zhongcheng Cong,1 Yifang Zou,1 Tianmeng Sun,3 Fionán Davitt,4,5 Adrià Garcia-Gil,4,5 Justin D Holmes,4,5 Caitriona M O’Driscoll,6 Kamil Rahme,4,7 Jianfeng Guo1 1School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China; 2De...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wang L, Pei J, Cong Z, Zou Y, Sun T, Davitt F, Garcia-Gil A, Holmes JD, O’Driscoll CM, Rahme K, Guo J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Non-viral drug delivery chemotherapy photothermal therapy synergistic effect Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/f247afa5edba483181c67b76f689353a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f247afa5edba483181c67b76f689353a
record_format	dspace
spelling	oai:doaj.org-article:f247afa5edba483181c67b76f689353a2021-12-02T05:33:17ZDevelopment of anisamide-targeted PEGylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice1178-2013https://doaj.org/article/f247afa5edba483181c67b76f689353a2019-03-01T00:00:00Zhttps://www.dovepress.com/development-of-anisamide-targeted-pegylated-gold-nanorods-to-deliver-e-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Limei Wang,1,2 Jin Pei,1 Zhongcheng Cong,1 Yifang Zou,1 Tianmeng Sun,3 Fionán Davitt,4,5 Adrià Garcia-Gil,4,5 Justin D Holmes,4,5 Caitriona M O’Driscoll,6 Kamil Rahme,4,7 Jianfeng Guo1 1School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China; 2Department of Pharmacy, The General Hospital of FAW, Changchun 130011, China; 3The First Hospital of Jilin University, Changchun 130021, China; 4School of Chemistry and the Tyndall National Institute, University College Cork, Cork, Ireland; 5CRANN, Trinity College Dublin, Dublin, Ireland; 6Pharmacodelivery Group, School of Pharmacy, University College Cork, Cork, Ireland; 7Department of Sciences, Faculty of Natural and Applied Science, Notre Dame University (Louaize), Zouk Mosbeh 1200, Lebanon Background: Gold nanorods (AuNRs), due to the optical and electronic properties namely the surface plasma resonance, have been developed to achieve the light-mediated photothermal therapy (PTT) for cancer. However, PTT alone may suffer from inefficient tumor killing. Recently, the combination of PTT and chemotherapy has been utilized to achieve synergistic anticancer effects. Methods: In this study, AuNRs capped with hexadecyltrimethylammonium bromide (CTAB), poly(acrylic acid) (PAA), and PEGylated anisamide (a ligand known to target the sigma receptor) have been developed to produce a range of negatively charged anisamide-targeted PEGylated AuNRs (namely Au-CTAB-PAA-PEG-AA) for the combination of PTT and chemotherapy (termed as chemo-photothermal therapy [CPTT]). Epirubicin (EPI, an anthracycline drug) was efficiently loaded onto the surface of Au800-CTAB-PAA-PEG-AA via the electrostatic interaction forming Au800-CTAB-PAA-PEG-AA.EPI complex. Results: The resultant complex demonstrated pH-dependent drug release, facilitated nucleus trafficking of EPI, and induced antiproliferative effects in human prostate cancer PC-3 cells. When Au800-CTAB-PAA-PEG-AA.EPI complex was further stimulated with desired laser irradiation, the synergistic outcome was evident in PC-3 xenograft mice. Conclusion: These results demonstrate a promising strategy for clinical application of CPTT in cancer. Keywords: gold nanoparticles, non-viral drug delivery, chemotherapy, photothermal therapy, synergistic effectWang LPei JCong ZZou YSun TDavitt FGarcia-Gil AHolmes JDO’Driscoll CMRahme KGuo JDove Medical PressarticleNon-viral drug deliverychemotherapyphotothermal therapysynergistic effectMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 1817-1833 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Non-viral drug delivery chemotherapy photothermal therapy synergistic effect Medicine (General) R5-920
spellingShingle	Non-viral drug delivery chemotherapy photothermal therapy synergistic effect Medicine (General) R5-920 Wang L Pei J Cong Z Zou Y Sun T Davitt F Garcia-Gil A Holmes JD O’Driscoll CM Rahme K Guo J Development of anisamide-targeted PEGylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice
description	Limei Wang,1,2 Jin Pei,1 Zhongcheng Cong,1 Yifang Zou,1 Tianmeng Sun,3 Fionán Davitt,4,5 Adrià Garcia-Gil,4,5 Justin D Holmes,4,5 Caitriona M O’Driscoll,6 Kamil Rahme,4,7 Jianfeng Guo1 1School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China; 2Department of Pharmacy, The General Hospital of FAW, Changchun 130011, China; 3The First Hospital of Jilin University, Changchun 130021, China; 4School of Chemistry and the Tyndall National Institute, University College Cork, Cork, Ireland; 5CRANN, Trinity College Dublin, Dublin, Ireland; 6Pharmacodelivery Group, School of Pharmacy, University College Cork, Cork, Ireland; 7Department of Sciences, Faculty of Natural and Applied Science, Notre Dame University (Louaize), Zouk Mosbeh 1200, Lebanon Background: Gold nanorods (AuNRs), due to the optical and electronic properties namely the surface plasma resonance, have been developed to achieve the light-mediated photothermal therapy (PTT) for cancer. However, PTT alone may suffer from inefficient tumor killing. Recently, the combination of PTT and chemotherapy has been utilized to achieve synergistic anticancer effects. Methods: In this study, AuNRs capped with hexadecyltrimethylammonium bromide (CTAB), poly(acrylic acid) (PAA), and PEGylated anisamide (a ligand known to target the sigma receptor) have been developed to produce a range of negatively charged anisamide-targeted PEGylated AuNRs (namely Au-CTAB-PAA-PEG-AA) for the combination of PTT and chemotherapy (termed as chemo-photothermal therapy [CPTT]). Epirubicin (EPI, an anthracycline drug) was efficiently loaded onto the surface of Au800-CTAB-PAA-PEG-AA via the electrostatic interaction forming Au800-CTAB-PAA-PEG-AA.EPI complex. Results: The resultant complex demonstrated pH-dependent drug release, facilitated nucleus trafficking of EPI, and induced antiproliferative effects in human prostate cancer PC-3 cells. When Au800-CTAB-PAA-PEG-AA.EPI complex was further stimulated with desired laser irradiation, the synergistic outcome was evident in PC-3 xenograft mice. Conclusion: These results demonstrate a promising strategy for clinical application of CPTT in cancer. Keywords: gold nanoparticles, non-viral drug delivery, chemotherapy, photothermal therapy, synergistic effect
format	article
author	Wang L Pei J Cong Z Zou Y Sun T Davitt F Garcia-Gil A Holmes JD O’Driscoll CM Rahme K Guo J
author_facet	Wang L Pei J Cong Z Zou Y Sun T Davitt F Garcia-Gil A Holmes JD O’Driscoll CM Rahme K Guo J
author_sort	Wang L
title	Development of anisamide-targeted PEGylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice
title_short	Development of anisamide-targeted PEGylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice
title_full	Development of anisamide-targeted PEGylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice
title_fullStr	Development of anisamide-targeted PEGylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice
title_full_unstemmed	Development of anisamide-targeted PEGylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice
title_sort	development of anisamide-targeted pegylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/f247afa5edba483181c67b76f689353a
work_keys_str_mv	AT wangl developmentofanisamidetargetedpegylatedgoldnanorodstodeliverepirubicinforchemophotothermaltherapyintumorbearingmice AT peij developmentofanisamidetargetedpegylatedgoldnanorodstodeliverepirubicinforchemophotothermaltherapyintumorbearingmice AT congz developmentofanisamidetargetedpegylatedgoldnanorodstodeliverepirubicinforchemophotothermaltherapyintumorbearingmice AT zouy developmentofanisamidetargetedpegylatedgoldnanorodstodeliverepirubicinforchemophotothermaltherapyintumorbearingmice AT sunt developmentofanisamidetargetedpegylatedgoldnanorodstodeliverepirubicinforchemophotothermaltherapyintumorbearingmice AT davittf developmentofanisamidetargetedpegylatedgoldnanorodstodeliverepirubicinforchemophotothermaltherapyintumorbearingmice AT garciagila developmentofanisamidetargetedpegylatedgoldnanorodstodeliverepirubicinforchemophotothermaltherapyintumorbearingmice AT holmesjd developmentofanisamidetargetedpegylatedgoldnanorodstodeliverepirubicinforchemophotothermaltherapyintumorbearingmice AT odriscollcm developmentofanisamidetargetedpegylatedgoldnanorodstodeliverepirubicinforchemophotothermaltherapyintumorbearingmice AT rahmek developmentofanisamidetargetedpegylatedgoldnanorodstodeliverepirubicinforchemophotothermaltherapyintumorbearingmice AT guoj developmentofanisamidetargetedpegylatedgoldnanorodstodeliverepirubicinforchemophotothermaltherapyintumorbearingmice
_version_	1718400388702404608

Development of anisamide-targeted PEGylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice

Ejemplares similares